GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Afrocentric Investment Corp Ltd (JSE:ACT) » Definitions » Revenue per Share

Afrocentric Investment (JSE:ACT) Revenue per Share : R12.18 (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Afrocentric Investment Revenue per Share?

Afrocentric Investment's revenue per share for the six months ended in Dec. 2023 was R5.18. Afrocentric Investment's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was R12.18.

Warning Sign:

Afrocentric Investment Corp Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Afrocentric Investment was -17.30% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 9.30% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 14.60% per year. During the past 10 years, the average Revenue Per Share Growth Rate was 15.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Afrocentric Investment's Revenue per Share or its related term are showing as below:

JSE:ACT' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -1.9   Med: 13.9   Max: 21.9
Current: 9.3

During the past 13 years, Afrocentric Investment's highest 3-Year average Revenue Per Share Growth Rate was 21.90% per year. The lowest was -1.90% per year. And the median was 13.90% per year.

JSE:ACT's 3-Year Revenue Growth Rate is ranked worse than
51.62% of 587 companies
in the Healthcare Providers & Services industry
Industry Median: 9.7 vs JSE:ACT: 9.30

Afrocentric Investment Revenue per Share Historical Data

The historical data trend for Afrocentric Investment's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Afrocentric Investment Revenue per Share Chart

Afrocentric Investment Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.30 10.95 13.66 14.59 14.29

Afrocentric Investment Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.17 7.42 7.31 6.99 5.18

Competitive Comparison of Afrocentric Investment's Revenue per Share

For the Medical Care Facilities subindustry, Afrocentric Investment's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Afrocentric Investment's PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Afrocentric Investment's PS Ratio distribution charts can be found below:

* The bar in red indicates where Afrocentric Investment's PS Ratio falls into.



Afrocentric Investment Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Afrocentric Investment's Revenue Per Share for the fiscal year that ended in Jun. 2023 is calculated as

Revenue Per Share (A: Jun. 2023 )=Revenue (A: Jun. 2023 )/Shares Outstanding (Diluted Average) (A: Jun. 2023 )
=8868.032/620.634
=14.29

Afrocentric Investment's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )=Revenue (Q: Dec. 2023 )/Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
=4384.386/845.834
=5.18

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was R12.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Afrocentric Investment  (JSE:ACT) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Afrocentric Investment Revenue per Share Related Terms

Thank you for viewing the detailed overview of Afrocentric Investment's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Afrocentric Investment (JSE:ACT) Business Description

Traded in Other Exchanges
N/A
Address
37 Conrad Road, Florida North, Roodepoort, ZAF, 1709
Afrocentric Investment Corp Ltd is a black-owned investment holding company with an investment portfolio focused on services to the healthcare sector. It seeks to invest in healthcare-related businesses that demonstrate prospects for growth as well as diversify its revenue sources while contributing to the sustainable health and welfare of South African communities. The company provides health administration and health risk management solutions to the healthcare industry. It also provides a range of complementary services to its traditional medical scheme clients and a portfolio of healthcare-related enterprises. These services include information technology solutions, transactional switching, specialized disease management, pharmaceutical wholesaling, amongst others.

Afrocentric Investment (JSE:ACT) Headlines

From GuruFocus

Enact Receives Ratings Upgrade from S&P Global Ratings

By sperokesalga sperokesalga 02-16-2023

Enact Enters Into $200 Million Revolving Credit Facility

By GuruFocusNews GuruFocusNews 07-07-2022

Enact Announces Neenu Kainth as Chief Customer Experience Officer

By GlobeNewswire GlobeNewswire 08-22-2022

Enact Announces Quarterly Dividend

By sperokesalga sperokesalga 02-09-2023

Enact Welcomes Jerome Upton to its Board of Directors

By sperokesalga sperokesalga 03-02-2023

Enact To Participate at the Bank of America 2023 Financial Services Conference

By Stock market mentor Stock market mentor 02-03-2023